tert-Butyl 1-(4-bromobenzoyl)piperidin-4-ylcarbamate
|
- $174 - $729
- Product name: tert-Butyl 1-(4-bromobenzoyl)piperidin-4-ylcarbamate
- CAS: 1286274-89-2
- MF: C17H23BrN2O3
- MW: 383.28
- EINECS:
- MDL Number:MFCD17014397
- Synonyms:tert-Butyl 1-(4-bromobenzoyl)piperidin-4-ylcarbamate;Carbamic acid, N-[1-(4-bromobenzoyl)-4-piperidinyl]-, 1,1-dimethylethyl ester
4 prices
Selected condition：
Brand
- aablocks
- Crysdot
Package
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01F8DN
- Product descriptiontert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95%
- Packaging100mg
- Price$174
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F8DN
- Product descriptiontert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95%
- Packaging250mg
- Price$285
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01F8DN
- Product descriptiontert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95%
- Packaging1g
- Price$729
- Updated2026-05-30
- Buy
- ManufacturerCrysdot
- Product numberCD11300308
- Product descriptiontert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 97%
- Packaging1g
- Price$309
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01F8DN | tert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95% | 100mg | $174 | 2026-05-30 | Buy |
| aablocks | AA01F8DN | tert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95% | 250mg | $285 | 2026-05-30 | Buy |
| aablocks | AA01F8DN | tert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 95% | 1g | $729 | 2026-05-30 | Buy |
| Crysdot | CD11300308 | tert-Butyl (1-(4-bromobenzoyl)piperidin-4-yl)carbamate 97% | 1g | $309 | 2026-05-26 | Buy |
Properties
Boiling point :507.7±50.0 °C(Predicted)
Density :1.37±0.1 g/cm3(Predicted)
pka :12.14±0.20(Predicted)
Density :1.37±0.1 g/cm3(Predicted)
pka :12.14±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|